Someone has sent you this link:
http://www.lytixbiopharma.com/

- Approval to start Phase IIa clinical trial with Lytixar™ (LTX-109)
- Lytix Biopharma and KAEL–GemVax announce approval of joint clinical trial
- Update on the Phase I clinical trials of Oncopore™ (LTX-315) for the treatment of cancer.
- Approval by the Swedish Medical Products Agency to commence a Phase I/IIa clinical trial